MDT | MedtronicNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history

$98.88
-$0.41 (-0.41%)

Medtronic (MDT) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $98.88 vs 50 $91.94 / 200 $88.17
Projection
No cross projected
Test
No active test
Last cross
Golden cross 23 Sep 2026 ยท projected 30 bars out ยท tested 5 bars

Weekly as of 30 Oct 16:00 ET

Price
above both $96.54 vs 50 $90.10 / 200 $86.41
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 8 Sep 2025 ยท projected 18 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $98.88 vs 50 $92.51 / 200 $88.30
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 Jul 2026 ยท projected 17 bars out

Cross history

35
crosses on record since 2017
18 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Sep 2026Golden steepdaily30 bars out5 bar cross test
29 Jul 2026Golden4-hour17 bars outNot tested
7 Apr 2026Death steepdaily26 bars outNot tested
11 Mar 2026Death4-hour27 bars outNot tested
week of 8 Sep 2025Golden flatweekly18 bars outNot tested

About MDT

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$863M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.